Mu, Ping <br/><br/>
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.  [electronic resource] 

 -  Science (New York, N.Y.)  01 2017 
 - 84-88 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1095-9203 
<br/><br/><label>Standard No.: </label>10.1126/science.aah4307  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--therapeutic use<br/>Benzamides<br/>Cell Line, Tumor<br/>Cell Lineage<br/>Cell Plasticity<br/>Humans<br/>Male<br/>Nitriles<br/>Phenylthiohydantoin--analogs & derivatives<br/>Prostatic Neoplasms--drug therapy<br/>Retinoblastoma Binding Proteins--genetics<br/>SOXB1 Transcription Factors--genetics<br/>Tumor Suppressor Protein p53--genetics<br/>Ubiquitin-Protein Ligases--genetics